Medicine & Life Sciences
Breast Neoplasms
100%
Tamoxifen
40%
Neoplasms
37%
Melanoma
37%
Aromatase Inhibitors
27%
Survival
26%
Drug Therapy
24%
Trastuzumab
23%
Therapeutics
22%
Recurrence
20%
Estrogen Receptors
18%
Cytochrome P-450 CYP2D6
17%
Progression-Free Survival
17%
Letrozole
17%
Carboplatin
14%
Paclitaxel
14%
pazopanib
14%
Neoadjuvant Therapy
12%
Breast
11%
Cyclophosphamide
11%
Aromatase
11%
Doxorubicin
11%
Anastrozole
11%
Breast Density
10%
Triple Negative Breast Neoplasms
10%
Confidence Intervals
10%
Disease-Free Survival
10%
Radiotherapy
10%
4-hydroxy-N-desmethyltamoxifen
10%
Polyurethanes
9%
Carcinoma
9%
Heterografts
9%
Neoplasm Metastasis
8%
Multiple Myeloma
8%
Adjuvant Chemotherapy
8%
Estrogens
7%
Biopsy
7%
Meta-Analysis
7%
Clinical Trials
7%
Serum
7%
Sentinel Lymph Node
7%
130-nm albumin-bound paclitaxel
7%
Lead
7%
Mortality
7%
Anaplastic Thyroid Carcinoma
7%
human ERBB2 protein
7%
Tumor Biomarkers
7%
Meningioma
6%
Endometrial Neoplasms
6%
exemestane
6%